{"public_id":"cl_ee5b3ab32f15a5709ccb4acdab5d25ed","status":"active","superseded_by_public_id":null,"corpus_id":7120096,"text":"Gemcitabine and cisplatin given on a 21-day schedule in an outpatient setting is active and well tolerated in advanced bladder cancer.","confidence":0.96,"paper":{"corpus_id":7120096,"title":"A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer","url":"https://sah.borca.ai/papers/7120096"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_192749d091e69fe710e7e9c333a85935","name":"21-day schedule","description":"A treatment cycle in which drugs are administered over a 3-week interval.","types":["schedule"],"url":"https://sah.borca.ai/concepts/co_192749d091e69fe710e7e9c333a85935"},{"public_id":"co_cf519a4efe7c5863cfba68d26b93f69b","name":"outpatient setting","description":"A non-inpatient treatment setting where patients receive therapy without hospital admission.","types":["care setting"],"url":"https://sah.borca.ai/concepts/co_cf519a4efe7c5863cfba68d26b93f69b"},{"public_id":"co_e32c699114393e7ddf8b2f1b11165a69","name":"gemcitabine and cisplatin","description":"A combination chemotherapy regimen using gemcitabine and cisplatin.","types":["treatment regimen"],"url":"https://sah.borca.ai/concepts/co_e32c699114393e7ddf8b2f1b11165a69"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_ee5b3ab32f15a5709ccb4acdab5d25ed"}